Suzhou Basecare Medical IPO: Trading Debut
Basecare priced its IPO at HK$27.36 and closed 14% up at HK$31.20 in the grey market. Our DCF sensitivity analysis shows that the IPO price is...
363 Views
Jinxin Fertility (锦欣生殖) Placement - Setting up for Acquisitions
Jinxin Fertility Co Ltd (1951 HK) is looking to raise US$167m in its top-up placement to fund potential acquisitions in China and Southeast Asia.
329 Views
Suzhou Basecare Medical IPO Initiation: Improving IVF
Basecare is pre-marketing for an HK IPO to raise $250 million. With a large addressable market opportunity and Basecare’s early mover advantage, we...
464 Views
Jinxin Fertility (锦欣生殖) Placement - Only Warburg Selling This Time
Amethyst Gem (Warburg Pincus) is looking to sell 80m shares in Jinxin Fertility Co Ltd (1951 HK). Post selldown, Amethyst Gem will still have...
348 Views
China Healthcare Weekly (Dec.11)
The article analyzed industry viewpoints about China ICL industry, TAVR industry and the assisted reproductive industry, and also included...
222 Views